Microbot Medical (NASDAQ:MBOT) Stock Price Passes Above 200-Day Moving Average – What’s Next?

Shares of Microbot Medical Inc. (NASDAQ:MBOT) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $1.36 and traded as high as $2.11. Microbot Medical shares last traded at $1.65, with a volume of 33,273,909 shares trading hands.

Analyst Ratings Changes

Separately, HC Wainwright lifted their target price on shares of Microbot Medical from $7.00 to $9.00 and gave the stock a “buy” rating in a report on Friday, January 24th.

Microbot Medical Price Performance

The firm has a market cap of $57.33 million, a P/E ratio of -2.06 and a beta of 1.40. The company’s 50 day moving average is $1.67 and its two-hundred day moving average is $1.36.

Microbot Medical (NASDAQ:MBOT) last released its quarterly earnings data on Wednesday, March 26th. The biotechnology company reported ($0.20) EPS for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.02). Research analysts predict that Microbot Medical Inc. will post -0.71 EPS for the current year.

Institutional Investors Weigh In On Microbot Medical

An institutional investor recently bought a new position in Microbot Medical stock. Renaissance Technologies LLC purchased a new stake in Microbot Medical Inc. (NASDAQ:MBOT) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 105,658 shares of the biotechnology company’s stock, valued at approximately $118,000. Renaissance Technologies LLC owned about 0.52% of Microbot Medical at the end of the most recent reporting period. Hedge funds and other institutional investors own 16.30% of the company’s stock.

Microbot Medical Company Profile

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.